The Agglutination of Tumour Cells in Vitro by Sera from Tumour Patients and Pregnant Women
1963

Agglutination of Tumor Cells by Serum from Patients and Pregnant Women

Sample size: 120 publication Evidence: moderate

Author Information

Author(s): C. Tal, T. Dishon, J. Gross

Primary Institution: The Hebrew University, Hadassah Medical School

Hypothesis

Is there an autoimmune mechanism against tumors reflected in the agglutination of tumor cells by serum from patients and pregnant women?

Conclusion

The study found that sera from patients with malignant diseases and pregnant women showed a high incidence of agglutination of tumor cells.

Supporting Evidence

  • 90% of sera from cancer patients caused agglutination of HeLa cells.
  • 100% of sera from pregnant women at term showed agglutination.
  • Only 16% of sera from patients with chronic diseases showed agglutination.

Takeaway

Doctors found that blood from cancer patients and pregnant women can make tumor cells stick together, which might help in understanding how the body fights cancer.

Methodology

The study involved preparing cell suspensions from various tumors and testing their agglutination with serum samples from patients and pregnant women.

Potential Biases

The testers were unaware of the serum origins, reducing potential bias.

Limitations

The study's conclusions are based on a limited number of serum samples from different sources.

Participant Demographics

The study included 120 patients with proven malignancy, 51 patients with chronic diseases, and 12 pregnant women.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication